SKI Market

A+| A| A-|

Indian Indices

Sensex

74,578.96 218.95
( 0.29%)

Global Indices

Nasdaq

51,596.42 888.35
(1.75%)

Dow Jones

7,607.58 32.90
(0.43%)

Hang Seng

67,369.16 -1,032.97
(-1.51%)

Nikkei 225

10,347.89 15.59
(0.15%)

Forex

USD-INR

95.72 0.48
(0.51%)

EUR-INR

111.14 0.31
(0.28%)

GBP-INR

128.64 0.40
(0.31%)

JPY-INR

0.60 0.00
(0.43%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Industry :

BSE Code

ISIN Demat

Book Value()

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

EPS(TTM)

Face Value()

Div & Yield %

Back

Vivanza Biosciences consolidated net profit rises 400.00% in the December 2025 quarter

Feb 12,2026

Net profit of Vivanza Biosciences rose 400.00% to Rs 0.20 crore in the quarter ended December 2025 as against Rs 0.04 crore during the previous quarter ended December 2024. Sales rose 2916.67% to Rs 45.25 crore in the quarter ended December 2025 as against Rs 1.50 crore during the previous quarter ended December 2024.

Particulars	Quarter Ended
	Dec. 2025	Dec. 2024	% Var.
Sales	45.25	1.50	2917
OPM %	0.46	8.00	-
PBDT	0.20	0.05	300
PBT	0.20	0.04	400
NP	0.20	0.04	400

74,578.96 218.95 ( 0.29%)

51,596.42 888.35 (1.75%)

7,607.58 32.90 (0.43%)

67,369.16 -1,032.97 (-1.51%)

10,347.89 15.59 (0.15%)

95.72 0.48 (0.51%)

111.14 0.31 (0.28%)

128.64 0.40 (0.31%)

0.60 0.00 (0.43%)